Analysed SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ) News Sources
Sagimet Biosciences Announces Poster and Oral Presentations at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
06-04-2026
yahoo.com
Analysts Remain Optimistic in Sagimet Biosciences (SGMT)’s Outlook Following Q4 and Full-Year 2025 Results
25-03-2026
yahoo.com
Sagimet Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates
11-03-2026
yahoo.com
Sagimet Biosciences Highlights Denifanstat MASH Data, Combo Plans at Oppenheimer Healthcare Conf.
01-03-2026
marketbeat.com
Sagimet Biosciences Announces Participation in Three Upcoming Investor Conferences
25-02-2026
yahoo.com
Sagimet Biosciences Showcases FASN Strategy, MASH Phase II Timeline and Acne Data at Guggenheim Conference
15-02-2026
marketbeat.com
Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences
05-02-2026
yahoo.com
A Look At Sagimet Biosciences (SGMT) Valuation After Denifanstat’s Phase 3 Acne Trial Success
05-02-2026
yahoo.com
What is the current price of SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ)?
The current price of SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ) is $6.19.
SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ) absolute price change since previous trading day?
The absolute price change of SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ) since the previous trading day is $0.12.
SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ) percentage price change since previous trading day?
The percentage price change of SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ) since the previous trading day is 1.9769%.
What is the most recent average sentiment score for SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ)?
The most recent average sentiment score for SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ)?
The most recent sentiment for SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ) is .
SEC-8K** Filing Available For SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.